| 000 | 01771 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514192534.0 | ||
| 264 | 0 | _c20040712 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa032845 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLange, Helmut | |
| 245 | 0 | 0 |
_aFolate therapy and in-stent restenosis after coronary stenting. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJun 2004 |
||
| 300 |
_a2673-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aCoronary Restenosis _xchemically induced |
| 650 | 0 | 4 |
_aCoronary Vessels _xpathology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid _xadverse effects |
| 650 | 0 | 4 |
_aHomocysteine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aVitamin B 12 _xadverse effects |
| 650 | 0 | 4 |
_aVitamin B 6 _xadverse effects |
| 700 | 1 | _aSuryapranata, Harry | |
| 700 | 1 | _aDe Luca, Giuseppe | |
| 700 | 1 | _aBörner, Caspar | |
| 700 | 1 | _aDille, Joep | |
| 700 | 1 | _aKallmayer, Klaus | |
| 700 | 1 | _aPasalary, M Noor | |
| 700 | 1 | _aScherer, Eberhard | |
| 700 | 1 | _aDambrink, Jan-Henk E | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 350 _gno. 26 _gp. 2673-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa032845 _zAvailable from publisher's website |
| 999 |
_c14920695 _d14920695 |
||